Royal Derby Hospital

The trials here

What the 33 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease5 trials
• Type 2 diabetes5 trials
• Childhood cancers3 trials
• Fatty liver disease (MASLD/MASH)3 trials
• Osteoarthritis3 trials
• Multiple myeloma2 trials
• Osteonecrosis (avascular necrosis)2 trials
• Prostate cancer2 trials
• Acute myeloid leukaemia1 trial
• Aortic aneurysm1 trial
• Cervical cancer1 trial
• Colorectal cancer1 trial
• and 18 more

Phase

• Phase 316 trials
• Phase 23 trials
• Phase 1/21 trial

Status

• Recruiting11 trials
• Active, not recruiting10 trials
• Completed10 trials
• Not yet recruiting2 trials

Lead sponsor

• University College, London4 trials
• University of Nottingham3 trials
• Boehringer Ingelheim2 trials
• Imperial College London2 trials
• Zimmer Biomet2 trials
• and 20 more

Running trials

• Recruiting

  A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing Haemodialysis

  NCT07422532· Imperial College London· Source

  Contact: Emma Wilmot, PhD

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  Postoperative Electrical Muscle Stimulation Two

  NCT06964438· University of Nottingham· Source

  Contact: Sawsan Abdul-Hamid, MBBS

• Recruiting

  Closed-loop in Adults With Type 2 Diabetes

  NCT06579404· University of Cambridge· Source

  Contact: Emma Wilmot

• Recruiting

  A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

  NCT06629779· Phase 3· Pfizer· Source

• Recruiting

  Study of WAL0921 in Patients With Glomerular Kidney Diseases

  NCT06466135· Phase 2· Walden Biosciences· Source

  Contact: Michelle Skupian

• Recruiting

  Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma

  NCT05635162· Phase 2· University College, London· Source

  Contact: Meghna Ruparelia

• Active, not recruiting

  CGM Use in Adults With Type 2 Diabetes on Basal Insulin

  NCT05944432· Abbott Diabetes Care· Source

• Recruiting

  A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

  NCT06461208· Phase 3· King's College London· Source

  Contact: Nicholas Taylor

• Recruiting

  A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT05085028· Phase 3· Imperial College London· Source

  Contact: Manjusha Keni

• Recruiting

  Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers

  NCT05604963· University College, London· Source

  Contact: Hazem Nijim (principal investigator)

• Active, not recruiting

  Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)

  NCT04546620· Phase 2· University Hospital Southampton NHS Foundation Trust· Source

• Active, not recruiting

  Application of Functional Renal MRI to Improve Assessment of Chronic Kidney Disease

  NCT04238299· University Hospitals of Derby and Burton NHS Foundation Trust· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Terumo Aortic Global Endovascular Registry

  NCT04246463· Vascutek Ltd.· Source

  Contact: Ganesh Dr Kuhan (principal investigator)

• Recruiting

  Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

  NCT04068597· Phase 1/2· CellCentric Ltd.· Source

  Contact: Firas Al-Kaisi, MD

• Active, not recruiting

  Anatomical Shoulder Domelock System Study

  NCT03312465· Zimmer Biomet· Source

• Recruiting

  The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

  NCT03562169· Phase 3· University of Leeds· Source

  Contact: David Allotey

• Active, not recruiting

  Persona Partial Knee Clinical Outcomes Study

  NCT03034811· Zimmer Biomet· Source

• Active, not recruiting

  National Unified Renal Translation Research Enterprise - Chronic Kidney Disease

  NCT04084145· University of Nottingham· Source

• Active, not recruiting

  Total Ankle Replacement Versus Arthrodesis Trial

  NCT02128555· University College, London· Source

• Active, not recruiting

  Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer

  NCT01566240· Phase 3· University College, London· Source

• Active, not recruiting

  Prostate Advances in Comparative Evidence

  NCT01584258· Phase 3· Royal Marsden NHS Foundation Trust· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes3 recruiting
• Multiple myeloma2 recruiting
• Acute myeloid leukaemia1 recruiting
• Aortic aneurysm1 recruiting
• Childhood cancers1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• High blood pressure1 recruiting
• IgA nephropathy1 recruiting
• Liver cirrhosis1 recruiting
• Lung cancer1 recruiting
• Mantle cell lymphoma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Nephrotic syndrome1 recruiting
• Prostate cancer1 recruiting
• Thyroid cancer1 recruiting

Closed trials

• Completed

  Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

  NCT05092399· University of Nottingham· Source

• Completed

  Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

  NCT04987203· Phase 3· AVEO Pharmaceuticals, Inc.· Source

• Completed

  A Trial of the May Health Device in Transvaginal Ablation of Ovarian Tissue Under ULTRAsound Visualization in Women With PCOS Infertility

  NCT03760926· May Health· Source

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Boehringer Ingelheim· Source

• Completed

  Atezolizumab Trial in Endometrial Cancer - AtTEnd

  NCT03603184· Phase 3· Mario Negri Institute for Pharmacological Research· Source

• Completed

  Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

  NCT03020303· Phase 3· Hamilton Health Sciences Corporation· Source

• Completed

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· Phase 3· Alfasigma S.p.A.· Source

• Completed

  Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke

  NCT02898610· Phase 3· University College Dublin· Source

• Completed

  Stereotactic Radiotherapy for Wet AMD (STAR)

  NCT02243878· Phase 3· King's College Hospital NHS Trust· Source

• Completed

  Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours

  NCT01726374· Phase 3· Institute of Cancer Research, United Kingdom· Source